Related Experiment Videos
Comparative genomics on Wnt5a and Wnt5b genes
1M & M Medical BioInformatics, Hongo 113-0033, Japan. mkatoh@ncc.go.jp
International Journal of Molecular Medicine
|March 9, 2005
Summary
This study identifies and characterizes rat Wnt5a and Wnt5b genes, revealing conserved regulatory elements in Wnt5a promoters but divergence in Wnt5b promoters between rodents and humans.
Area of Science:
- Genomics
- Comparative Biology
- Molecular Biology
Background:
- Canonical WNT pathways drive carcinogenesis, while non-canonical pathways like planar cell polarity (PCP) promote metastasis.
- WNT5A and WNT5B are human paralogous genes involved in distinct cellular processes.
- Understanding WNT5A and WNT5B gene evolution and regulation is crucial for disease research.
Purpose of the Study:
- To identify and characterize the rat Wnt5a and Wnt5b genes.
- To perform comparative genomics of Wnt5a and Wnt5b orthologs across species.
- To analyze the evolutionary conservation of Wnt5a and Wnt5b gene promoters.
Main Methods:
- Bioinformatic analysis of rat genome sequences (AC095764.5, AC112027.3).
- Identification and characterization of rat Wnt5a and Wnt5b gene structures and protein features.
- Comparative analysis of promoter regions between rat, mouse, and human WNT5A/WNT5B genes.
Main Results:
- Rat Wnt5a and Wnt5b genes, each with five exons, were identified.
- Both rat Wnt5a and Wnt5b are predicted secreted proteins with conserved cysteine residues and glycosylation sites.
- Rat Wnt5a promoter shows significant sequence identity and conserved transcription factor binding sites (E47, NKX2-5) with human WNT5A, unlike the divergent Wnt5b promoters.
Conclusions:
- This is the first report detailing rat Wnt5a and Wnt5b genes and their comparative genomics.
- Conserved regulatory elements in Wnt5a promoters suggest functional conservation, while Wnt5b promoter divergence may indicate species-specific roles.
- Further research is needed to elucidate the role of WNT5B in human adipogenesis and its association with type 2 diabetes.